The rising demand for probiotics is one of the most interesting trends amongst pharmaceutical companies. Probiotics are helpful bacteria and are often used to help the immune system and aid digestion. Probiotics are most commonly found in yogurts, baby formulas and pills but the uses are expanding. To date, the probiotics industry has grown almost 20% in the past year with Asian demand leading the way.
While the global economy still recovers, the growing demand for probiotics is an exciting trend for the pharmaceuticals industry. The fact that probiotics can be found in everyday products like yogurt and dairy products distinguishes it from the typically medicinal usage of pharmaceutical products.
Probiotics also differ from typical pharmaceutical products in the sense that new variants don't linger for years in extensive multistage drug trials. Probiotics go from development to the market at a much faster rate. In a recovering economy where time is critical, probiotics are an increasingly marketable and profitable product and one company making great strides as an emerging producer of probiotics is China-Biotics Inc. Investors looking for complimentary research on China-Biotics Inc.
China-Biotics Inc. will be releasing its Q3 2010 results on November 15th. Another player in the drug related products set to release its earnings late this month is Auxilium Pharmaceuticals Inc. Investors looking for free research on Auxilium Pharmaceuticals Inc.
No comments:
Post a Comment